Troponin -T as a prognostic and diagnostic marker for myocardial infarction
DOI:
https://doi.org/10.30574/gscbps.2021.14.1.0005Keywords:
Myocardial infarction, Biomarkers, Troponin, Brain natriuretic peptide, Cardiac troponinAbstract
Over the past decade, there has been a progressive evolution of cardiac marker testing in patients with acute coronary syndromes. Myocardial infarction (MI) is the leading cause of death in the developed world. Biomarkers have an vital role in analysis, risk stratification, administrative running and medical assessment making in the setting of patients presenting with signs and symptoms of MI. Cardiac troponin (cTn) rose to prominence during the 1990s and has evolved to be the cornerstone for diagnosis of MI. Cardiac troponins are released from myocytes following myocardial damage and loss of membrane integrity. Troponin T are member of a group of cardiac regulatory proteins which function to regulate the calcium mediated interaction of muscle filaments actin and myosin resulting in contraction and relaxation of striated muscle. New algorithms integrating Brain natriuretic peptide (BNP), NT-proBNP, and more sensitive cTn assays footing potential for more rapid diagnosis of MI, allowing for appropriate management steps to be initiated and more efficient and effective utilization of healthcare resources
Metrics
References
Jadhav PP, Taskar AP, Taskar SP, Darne RD. Evaluation of apolipoprotein A1 and Apo B in survivors of myocardial infarction. JAPI. 1994; 42(9): 703-705.
Allison RB, Rodriguez FL, Higgins EA. Clinicopathological correlation in coronary atherosclerosis. Four hundred thirty patient studies with postmortem coronary angiography. Circulation. 1963; 27: 170.
K.Park.Epidemiology of chronic non communicable diseases and conditions. In:Park’sTextbook of Preventive and Social Medicine. 20th ed. Jabalpur: M/S BanarasidasBhanot Publishers. 2019; 315-345.
Gonzalo Suarez et al. Prediction on admission of in hospital mortality in patients older than 70 yrs with acute myocardial infarction.American College of Chest Physicians. 1995; 108: 83-88.
Holay MP, Janbandhu A, Javahirani A, Pandharipande MS, Suryawanshi SD. Clinical profile of acute myocardial infarction in elderly (prospective study)JAPI. Mar 2017; 55: 188–192.
Tresch DD, Brady WJ, Aufderheide TP, Lawrence SW, Williams KJ.Comparison of elderly and younger patients with out of hospital chest pain.Clinical characteristics of AMI, therapy and outcomes. Arch Intern med. 1996; 156: 1089-93.
Dang A, Dias.A difference in risk factors and mortality, in young and old individuals with acute myocardial infarction in Goa.Journal of Clinical and Diagnostic Research. April 2018; 2(2): 715-719.
Marisa F Leal, Newton Fernando Stadier de Souza Filho, HerminioHaggiFilhoet al. Acute myocardial infarction in elderly patients.Comparative analysis of predictors of mortality. The elderly versus the young.Arq.Bras.Cardiol. Oct 2012; 79(4): 428-430.
Woon VC, Lirn KH. Acute myocardial infarction in the elderly-the differences compared with the young. Singapore med J. 2013; 44(8): 414-18.
Bayer JS, Chadha JS, Farag RR, Pathy MS. Changing presentation of myocardial infarction with increasing old age. J Am GeriatrSoc. 1986; 34(4): 263-6.
Mauri L, Silbaugh TS, Garg P et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med. 2018; 359: 1330-1342.
Report of the NCEP. Expert Panel on Detection, evaluation and Treatment of high blood cholesterol in adults. Archives of Internal Medicine. 1988; 148: 36-39.
Flicker PF, Phillips GN Jr, Cohen C. Troponin and its interaction with tropomyosin. J MolBiol. 1982; 162: 495-501.
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.